Medicare Enrolled

Dr. Robert Gazmarian, M.D.

Orthopedic Surgery · Van Nuys, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
6815 NOBLE AVE, Van Nuys, CA 91405
8189016600
In practice since 2006 (19 years)
NPI: 1588691174 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gazmarian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gazmarian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gazmarian

Dr. Robert Gazmarian is an orthopedic surgery specialist in Van Nuys, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gazmarian performed 6,909 Medicare services across 2,721 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gazmarian received a total of $1,049 from 11 pharmaceutical and/or device companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in orthopedic surgery. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gazmarian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 6% volume in CA $1,049 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,909
Medicare services
Top 6% in CA for orthopedic surgery
2,721
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~364 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Extended-release steroid injection (Zilretta)
An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams.
3,648 $13 $82
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
630 $104 $858
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
544 $84 $625
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
543 $134 $1,085
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
187 $5 $30
Nerve conduction studies, 5-6 tests
A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction.
177 $113 $707
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
175 $176 $1,128
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
162 $94 $525
X-ray of lower and sacral spine, 2-3 views
An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area.
156 $33 $206
Knee X-ray, 4 or more views
An imaging test using X-rays to create multiple pictures of the knee joint from different angles.
133 $40 $218
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
96 $62 $468
Shoulder X-ray, 2+ views
An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures.
70 $29 $161
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
50 $92 $1,490
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
44 $69 $508
Knee X-ray, 3 views
An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures.
37 $37 $198
X-ray of upper spine, 2-3 views
An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures.
36 $34 $195
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
36 $79 $864
Hyaluronan intra-articular injection
An injection of hyaluronan or a derivative into a joint to provide lubrication and cushioning.
28 $553 $3,306
Pelvis X-ray, 1-2 views
An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints.
26 $23 $174
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
26 $115 $960
Ankle X-ray, minimum 3 views
An X-ray imaging test of the ankle that captures at least three different angles to evaluate the bones and joints.
18 $32 $174
X-ray of hand, minimum of 3 views
An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints.
16 $29 $178
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
16 $154 $933
Foot X-ray, 3+ views
An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints.
15 $31 $167
Ultrasound-guided joint aspiration or injection
Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement.
14 $71 $443
New patient office visit, complex (60-74 min) 14 $119 $1,360
X-ray of middle spine, 2 views
An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints.
12 $28 $184
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,049
Total received (2018-2024)
Avg $175/year across 6 years
Bottom 35% in CA for orthopedic surgery
11
Companies
38
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,049 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15
2023
$47
2021
$608
2020
$93
2019
$62
2018
$224

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Pacira Pharmaceuticals Incorporated
$15
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Pacira Therapeutics, Inc.
$389
Nevro Corp.
$163
Smith & Nephew, Inc.
$157
DePuy Synthes Sales Inc.
$128
Flexion Therapeutics, Inc.
$69
NATUS MEDICAL INCORPORATED
$37
IBSA Pharma Inc.
$25
Ferring Pharmaceuticals Inc.
$24
Vision Quest Industries Inc.
$22
PFIZER INC.
$21
Pacira Pharmaceuticals Incorporated
$15
Top 3 companies account for 67.6% of all-time payments
Associated products mentioned in payments ›
EUFLEXXA · Exparel · FIRSTPASS MINI · LICART · LYRICA · MONOVISC · ORTHOVISC · Omnia · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an orthopedic surgery specialist in Van Nuys?
Compare orthopedic surgeons in the Van Nuys area by procedure volume, costs, and industry payment transparency.
Browse orthopedic surgeons nearby

Geographic Context

Orthopedic surgeons within 10 mi
435
Per 100K population
4.4
County median income
$87,760
Nearest hospital
VALLEY PRESBYTERIAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gazmarian is a clinical cardiology specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gazmarian experienced with extended-release steroid injection (zilretta)?
Based on Medicare claims data, Dr. Gazmarian performed 3,648 extended-release steroid injection (zilretta) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gazmarian receive payments from pharmaceutical companies?
Yes. Dr. Gazmarian received a total of $1,049 from 11 companies across 38 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gazmarian's costs compare to other orthopedic surgeons in Van Nuys?
Dr. Gazmarian's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gazmarian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →